Therefore, the aim of this study was to identify sAPRIL specific binding peptides using a phage display library, and to evaluate its in vitro and in vivo anti-cancer effects to provide a therapeutic candidate for use against colorectal cancers that express high levels of APRIL. Here, TNFSF13 is linked to colorectal cancer.